Drug name - Cuvposa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7638552 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate Aug, 2023

(10 months from now)

US7816396 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate Aug, 2023

(10 months from now)

Drugs and Companies using GLYCOPYRROLATE ingredient

Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
1MG/5ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.